James New, Paul Queally, David Redmond, Joseph Sonnier, Martin Stefanelli, Thomas White, Michael Dent, Richard Barker, James Meade, Paul Young, Steve Hobbs, Ron Binns, Henry Friesen, Rick Episcopo, John Boyce, Kevin Krenitsky | GenomeWeb

AmeriPath chairman and CEO James New will retire on Feb. 1. Paul Queally, who is a director at the company, has been appointed chairman. A search for a new CEO will begin immediately, AmeriPath said.

In the meantime, the company will be run by the office of the CEO, including CFO David Redmond, president Joseph Sonnier, and COO Martin Stefanelli.

New has been the CEO of the company since AmeriPath was founded. Queally is also a general partner with Welsh Carson, Anderson & Stowe.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.